1
|
Duvuru S, Sanker V, Mishra RK, Sharma AK, Lim SL, Baskar N, Sharma VK. Ancillary tests for brain death. Front Neurol 2025; 15:1491263. [PMID: 39839883 PMCID: PMC11747481 DOI: 10.3389/fneur.2024.1491263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2024] [Accepted: 12/13/2024] [Indexed: 01/23/2025] Open
Abstract
Background Ancillary tests are often used in the determination of death by neurologic criteria (DNC), especially when the clinical examination is inconclusive. DNC is widely accepted, as defined by the comprehensive report of the World Brain Death Project. However, there are several medical, legal, religious, ethical, and social controversies. Accordingly, "premature" and "delayed" diagnoses of brain death attract these issues. Methods Depending upon the availability and experience of the managing medical teams, various ancillary tests are employed for an early and supplementary diagnosis of brain death. Results We describe the practicality, test performance, and utility of some of the commonly employed ancillary tests for the diagnosis of brain death in clinical practice, along with their case examples. Conclusion Brain death is a clinical diagnosis determined by history, physical examination, and adherence to recommended criteria. All ancillary investigations are used as supplementary tests with variable accuracy parameters. These ancillary tests often facilitate an early and "timely" diagnosis of brain death.
Collapse
Affiliation(s)
| | | | - Rajeeb Kumar Mishra
- National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
| | | | - Shir Lynn Lim
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | | | - Vijay K. Sharma
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| |
Collapse
|
2
|
Almus E, Bıyıklı E, Yapıcı Ö, Almus F, Girgin Fİ, Öztürk N. Brain death in children: is computed tomography angiography reliable as an ancillary test? Pediatr Radiol 2023; 53:131-141. [PMID: 35731261 DOI: 10.1007/s00247-022-05419-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Revised: 05/19/2022] [Accepted: 06/02/2022] [Indexed: 01/24/2023]
Abstract
BACKGROUND The diagnosis of brain death is primarily clinical. Sometimes ancillary tests are needed. OBJECTIVE This study compared sensitivity and interobserver agreement of the 10-, 7- and 4-point CT angiography scoring systems for the diagnosis of brain death in children. MATERIALS AND METHODS CT angiography examinations of 50 pediatric patients with a clinical diagnosis of brain death were evaluated according to 10-, 7- and 4-point scoring systems. Images were evaluated by two radiologists who considered the vessel opacification first in the arterial phase (A0-V50) and then in the venous phase (A0-V50). We evaluated interobserver agreement for the assessment of vessel opacification and diagnosis of brain death. We compared the differences among brain death diagnoses between children with craniotomy-craniectomy defects, open fontanelles and preserved bone integrity. We subdivided children into two groups according to age: ≤ 2 years and > 2 years. We calculated sensitivities according to age groups. RESULTS Using the clinical exam as the reference standard, we found sensitivities for 10-, 7- and 4-point scoring systems to be 70%, 88% and 92% in the A0-V50 method and 40%, 82% and 82% in the A50-V50 method, respectively. Percentage agreement between readers was 78% for the 7-point scale using the A0-V50 method and more than 90% for other scoring systems for both the A0-V50 method and the A50-V50 method. The sensitivity was much lower in children with open anterior fontanelles compared to the groups with preserved bone integrity and with a craniotomy-craniectomy defect. CONCLUSION Just as in adult age groups, in children the 4-point scale appears to be more sensitive than the 10- and 7-point scales for CT angiography-based assessment of brain death. Because the scoring systems have similar sensitivities, they could be used as ancillary tests in pediatric cases.
Collapse
Affiliation(s)
- Eda Almus
- Department of Radiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
| | - Erhan Bıyıklı
- Department of Radiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey
| | - Özge Yapıcı
- Department of Radiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey
| | - Ferdağ Almus
- Department of Radiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey
| | - Feyza İnceköy Girgin
- Department of Pediatrics, Pediatric Intensive Care Unit, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey
| | - Nilüfer Öztürk
- Department of Pediatrics, Pediatric Intensive Care Unit, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey
| |
Collapse
|
3
|
Corrêa DG, de Souza SR, Nunes PGC, Coutinho Jr. AC, da Cruz Jr. LCH. The role of neuroimaging in the determination of brain death. Radiol Bras 2022; 55:365-372. [PMID: 36514681 PMCID: PMC9743262 DOI: 10.1590/0100-3984.2022.0016] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Accepted: 03/24/2022] [Indexed: 11/16/2022] Open
Abstract
Brain death is the irreversible cessation of all brain function. Although protocols for its determination vary among countries, the concept of brain death is widely accepted, despite ethical and religious issues. The pathophysiology of brain death is related to hypoxia and ischemia in the setting of extensive brain injury. It is also related to the effects of brain edema, which increases intracranial pressure, leading to cerebral circulatory arrest. Although the diagnosis of brain death is based on clinical parameters, the use of neuroimaging to demonstrate diffuse brain injury as the cause of coma prior to definitive clinical examination is a prerequisite. Brain computed tomography (CT) and magnetic resonance imaging (MRI) demonstrate diffuse edema, as well as ventricular and sulcal effacement, together with brain herniation. Angiography (by CT or MRI) demonstrates the absence of intracranial arterial and venous flow. In some countries, electroencephalography, cerebral digital subtraction angiography, transcranial Doppler ultrasound, or scintigraphy/single-photon emission CT are currently used for the definitive diagnosis of brain death. Although the definition of brain death relies on clinical features, radiologists could play an important role in the early recognition of global hypoxic-ischemic injury and the absence of cerebral vascular perfusion.
Collapse
Affiliation(s)
- Diogo Goulart Corrêa
- Department of Radiology, Clínica de Diagnóstico por Imagem
(CDPI)/Dasa, Rio de Janeiro, RJ, Brazil
- Department of Radiology, Universidade Federal Fluminense (UFF),
Niterói, RJ, Brazil
| | - Simone Rachid de Souza
- Department of Pathology, Universidade Federal do Rio de Janeiro (UFRJ), Rio
de Janeiro, RJ, Brazil
| | | | - Antonio Carlos Coutinho Jr.
- Department of Radiology, Clínica de Diagnóstico por Imagem
(CDPI)/Dasa, Rio de Janeiro, RJ, Brazil
- Department of Radiology, Fátima Digittal, Casa de Saúde Nossa
Senhora de Fátima, Nova Iguaçu, RJ, Brazil
| | | |
Collapse
|
6
|
Zampakis P, Panagiotopoulos V, Kalogeropoulou C, Karachaliou M, Aretha D, Sioulas N, Dimoulia S, Karnabatidis D, Fligou F. Computed tomography angiography scoring systems and the role of skull defects in the confirmation of brain death. Sci Rep 2021; 11:15081. [PMID: 34302043 PMCID: PMC8302591 DOI: 10.1038/s41598-021-94763-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Accepted: 07/15/2021] [Indexed: 01/07/2023] Open
Abstract
To assess and compare all current computed tomography angiography (CTA) scoring systems for the diagnostic workup of brain death (BD) to digital subtraction angiography (DSA) and clinical tests. Fifty-two patients with a clinical suspicion of BD underwent CTA and subsequently DSA. The diagnostic performance of all current CTA scoring systems was compared to that of DSA, in all patients with a suspicion of BD. A comparison to clinical tests was made only in DSA-positive for BD patients (n = 49), since in DSA-negative BD patients (n = 3) clinical tests were not performed. Further subgroup analysis was performed in relation to skull defects (SDs) stratification. Statistical analysis was conducted by applying statistics-contingency tables, Cochran's-Q test and McNemar's test. The CTA -10, and -7- and all 4-point scoring systems, showed overall sensitivities of 81,6%, 87.8% and 95.9% respectively and 100% specificity, when compared to DSA. In patients with a clinical verification of BD, the CTA -10 and -7-point scoring systems were significantly inferior to clinical tests (p = 0.004 and p = 0.031), while the 4-point scoring systems showed no such difference (p = 0.5). All 4-point scoring systems showed 100% sensitivity in patients with a minor SD or no SD. In patients with a major SD, all CTA scoring systems (- 10, - 7- and all 4-point) were less sensitive (62.5%, 62.5% and 75% respectively). The presence of a major SD was associated with an 8 × relative risk for false negative results in all 4-point scoring systems. CTA showed excellent diagnostic performance in patients with a suspicion of BD. The 4-point CTA scoring systems are the most sensitive for the diagnosis of BD, although in patients with a major SD patient, the role of CTA is ambiguous.
Collapse
Affiliation(s)
- Petros Zampakis
- Department of Radiology, University Hospital of Patras GR, 265 04, Patras, Greece.
| | | | | | - Maria Karachaliou
- Department of Radiology, University Hospital of Patras GR, 265 04, Patras, Greece
| | - Diamanto Aretha
- Department of Anesthesiology and Intensive Care Medicine, University Hospital of Patras. GR, 265 04, Patras, Greece
| | - Nektarios Sioulas
- Department of Anesthesiology and Intensive Care Medicine, University Hospital of Patras. GR, 265 04, Patras, Greece
| | - Sofia Dimoulia
- Department of Radiology, University Hospital of Patras GR, 265 04, Patras, Greece
| | | | - Fotini Fligou
- Department of Anesthesiology and Intensive Care Medicine, University Hospital of Patras. GR, 265 04, Patras, Greece
| |
Collapse
|
8
|
Matiello M, Turner AC, Estrada J, Whitney CM, Kitch BT, Lee PT, Girkar U, Palacios R, Singla P, Schwamm L. Teleneurology-Enabled Determination of Death by Neurologic Criteria After Cardiac Arrest or Severe Neurologic Injury. Neurology 2021; 96:e1999-e2005. [PMID: 33637632 DOI: 10.1212/wnl.0000000000011751] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Accepted: 01/08/2021] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To determine whether providing teleneurology (TN) consultations aiding in determination of death by neurologic criteria (DNC) to a bedside intensivist is feasible and whether timely access and expert input increase the quality of the DNC examination and identification of potential organ donors, we reviewed retrospective data related to outcomes of such consultations. METHODS Between November 2017 and March 2019, TN consults were requested for sequential comatose patients in the intensive care unit (ICU). We recorded patients' demographic information, causes leading to coma or suspected DNC, and the results of TN consultations. We obtained data on the number of referrals to the organ bank and number of organ donors. RESULTS Ninety-nine consults were performed with a median time from request to start of the consult of 20.2 minutes (interquartile range 5.4-65.3 minutes). Eighty consults were requested for determination of prognosis, whereas 19 consults were requested for supervision of the DNC examination. In 1 of 80 (1.2%) prognostication consults, the patient was determined by the neurologist to require assessment of DNC and was found to meet DNC criteria; determination of DNC occurred in 11 of the 19 (57.9%) consultations for a supervised DNC examination. In a comparison of the pre-TN (94 months) and post-TN (17 months) periods, there was 2.56-fold increase in the proportion of patients meeting DNC criteria who were medically suitable for donation (pre-TN 8.9% vs post-TN 21.1%, p = 0.02) and a 2.12-fold increase in the proportion of donors (pre-TN 6.14% vs post-TN 13.1%, p = 0.14). CONCLUSIONS It is feasible to perform TN consultations for patients with severe neurologic damage and to allow expert supervision for DNC examination. Having a teleneurologist as part of the ICU assessment team helped differentiate severe neurologic deficits from DNC and was associated with increase in organ donation.
Collapse
Affiliation(s)
- Marcelo Matiello
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA.
| | - Ashby C Turner
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Juan Estrada
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Cynthia M Whitney
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Barrett T Kitch
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Patrick T Lee
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Uma Girkar
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Rafael Palacios
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Pooja Singla
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| | - Lee Schwamm
- From the Department of Neurology (M.M., A.C.T., J.E., C.M.W., L.S.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Critical Care Medicine (B.T.K.), Emerson Hospital, Concord; Department of Medicine (P.T.L.), North Shore Medical Center, Salem; Institute for Medical Engineering and Science (U.G., R.P.), Massachusetts Institute of Technology, Boston; Institute for Research in Technology (R.P.), Universidad Pontificia Comillas, Madrid, Spain; and Soar Management Consulting Group (P.S.), Boston, MA
| |
Collapse
|